Eli Lilly and Company
Condensed thiophene derivatives useful as NaPi-IIb inhibitors
Last updated:
Abstract:
The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease, and/or the cardiovascular disease associated with chronic kidney disease. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
8 Aug 2017
Issue date:
2 Mar 2021